Opioid-Sparing Regimens Show Promise in Hospital Pain Management

Angel Goenawan, MD Credit: Linkedin The opioid crisis has forced clinicians to reassess how they approach pain management, particularly in hospital settings, where acute pain is frequent and the urgency to control it can result in opioid overuse. Emerging evidence suggests that non-opioid regimens, using medications such as acetaminophen, NSAIDs, gabapentin, and select antidepressants, can … Read more

Combination of Statins, Ezetimibe Could Prevent Thousands of Heart Attacks

Margret Leósdóttir, MD, PhD Credit: Åsa Hansdotter Treating patients hospitalized with myocardial infarction (MI) with a lipid-lowering therapy (LLT) combination of statins and ezetimibe could prevent thousands of further cardiovascular events, according to new research from Lund University and Imperial College London.1 Cardiovascular disease (CVD) is statistically the most common cause of death globally, with … Read more

Selective Vidian Neurectomy Plus FESS Shows Long-Term Relief in Nasal Itching

Credit: Adobe Stock/ eddows A new study found that 3 years of functional endoscopic sinus surgery (FESS) combined with selective vidian neurectomy improved nasal symptoms in patients with allergic rhinitis, chronic rhinosinusitis with nasal polyps (CRSwNP), and asthma.1 “Both groups demonstrated significant symptom improvement and enhanced quality of life three years post-surgery,” wrote investigators, led … Read more

Besifovir Improves Renal, Bone Health in HBV Patients Receiving Long-Term TDF

Hyung Joon Yim Credit: KU Medicine New research suggests switching to besifovir dipivoxil maleate (BSV) therapy may improve renal and bone health in patients with chronic hepatitis B virus (HBV) previously receiving long-term tenofovir disoproxil fumarate (TDF) treatment.1 The randomized, open-label, active-controlled, non-inferiority phase 4 clinical trial found switching to a 48-week BSV therapy regimen … Read more

Top News for Healthcare Providers from the Week of 04/06

Welcome to The HCPFive, your go-to roundup for the latest healthcare news and breakthroughs, curated specifically for busy healthcare professionals. Each week, we highlight 5 key developments or headlines from healthcare that you need to know—whether it’s a cutting-edge treatment, regulatory updates, or innovations shaping the future of medicine. This week’s top stories included new … Read more

Mortality Risk Rises 2.7-Fold in Adults After Respiratory Syncytial Virus

Maria João Fonseca, PhD | Image Credit: Linkedin Presented at the European Society of Clinical Microbiology and Infectious Disease (ESCMID) Global 2025 Congress, a recent study from Denmark indicated that adults suffering from respiratory syncytial virus-associated acute respiratory infection (RSV-ARI) have a risk of mortality 2.7-fold higher than that of a healthy person.1,2 RSV-ARI refers … Read more

I fix botched plastic surgeries for a living… here are the common procedures you should never get

A doctor who specializes in fixing botched plastic surgery procedures has revealed how to avoid being maimed under the knife.  Dr Timothy Katzen has handled hundreds of patients over his more than 25 years of practice, including a number who were victims of ‘botched’ operations. Some of these were seeking a revision after a procedure, … Read more

ACP Issues Best Practice Advice for Marijuana Use in Chronic, Noncancer Pain

Isaac Opole, MD, PhDCredit: UCI School of Medicine The American College of Physicians (ACP) has announced new Best Practice Advice for use of cannabis or cannabinoids for managing chronic, noncancer pain. Published during the ACP Internal Medicine (IM) Meeting 2025, the document is intended to inform clinicians whose patients are considering cannabis or cannabinoids on … Read more

Rivaroxaban Akin to Warfarin for Left Ventricular Thrombus After MI

Jehangir Ali Shah, MBBS Credit: ACC Rivaroxaban achieved comparable efficacy and safety to warfarin in resolving left ventricular blood clots in patients hospitalized with myocardial infarction (MI) without displaying evidence of excess harm, including mortality and bleeding risks.1 The open-label, non-inferiority, randomized controlled RIVAWAR trial, presented at the American College of Cardiology (ACC) 2025 Annual … Read more

Hims & Hers Adds Mounjaro, Wegovy: Platform Expansion

Here’s a rewritten and expanded article based on the provided text, optimized for SEO, E-E-A-T, and U.S.readers, adhering to AP style and grammatical accuracy: hims & Hers Rides the Weight-Loss Wave: A Deep Dive into Strategy, Challenges, and the Future of Telehealth Table of Contents hims & Hers Rides the Weight-Loss Wave: A Deep Dive … Read more